Therapeutic EUS

Therapeutic EUS is a growing and exciting field that is advancing endoscopic treatments for patients with complex pancreaticobiliary diseases. This web page includes physician videos and case studies, and a step by step reference guide for the AXIOS™ Stent and Delivery System.*



 
 
 

Patient Stories

video
AXIOS™ System Offers Solution for Patient

Watch how this new stent technology offers a solution for a patient with symptomatic pancreatic fluid collection.

View Video

Focus on New Technologies: Lecture Series

video
Meet Kenneth Binmoeller, MD - Founder of the AXIOS™ Technology

Dr. Binmoeller talks about the future of interventional endoscopy and his passion for being inventive and innovative that led to the development of the AXIOS technology.

View Video

video
How the AXIOS™ Technology Works, Presented by Kenneth Binmoeller, MD

Dr. Binmoeller, founder of Xlumena and inventor of the AXIOS System, discusses the features and intended benefits of the AXIOS Stent and Delivery System.

View Video

Video Case Studies

video
How to Drain a Pseudocyst, Presented by Shyam Varadarajulu, MD

Dr. Varadarajulu uses the AXIOS System to drain a symptomatic pancreatic pseudocyst.

View Video

*The Boston Scientific Endoscopy Stent Tracker is a supplemental informational tool that does not substitute for or replace existing patient record keeping by the physician. The Boston Scientific Endoscopy Stent Tracker does not constitute professional medical recommendations, treatment, or advice. It is not intended to be used to diagnose, cure, treat, or prevent any condition or disease.
The AXIOS™ Stent and Electrocautery-Enhanced Delivery System Indications for Use:
• US: The AXIOS Stent and Electrocautery-Enhanced Delivery System is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts 6cm in size, with ? 70% fluid content that are adherent to the gastric or bowel wall. Once place, the AXIOS Stent functions as an access port allowing passage of standard and therapeutic endoscopes to facilitate debridement, irrigation and cystoscopy. The stent is intended for implantation up to 60 days and should be removed upon confirmation of pseudocyst resolution.
• Europe: The Hot AXIOS Stent and Electrocautery Enhanced Delivery System is indicated for use to facilitate transgastric or transduodenal endoscopic drainage of a pancreatic pseudocyst, walled-off necrosis (?70% fluid content) or the biliary tract.
Note: The Caution statements below are specific to the AXIOS Stent and Delivery System devices and are not applicable to the AXIOS Stent Tracker. The AXIOS Stent Tracker is not a medical device.